Monte Rosa Therapeutics, Inc. (GLUE)
13.38
-0.94
(-6.56%)
USD |
NASDAQ |
Aug 28, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Free Cash Flow : -32.08M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.08M |
| March 31, 2026 | -19.66M |
| December 31, 2025 | -27.50M |
| September 30, 2025 | 145.02M |
| June 30, 2025 | 23.85M |
| March 31, 2025 | 30.48M |
| December 31, 2024 | 38.01M |
| September 30, 2024 | -62.79M |
| June 30, 2024 | -67.76M |
| March 31, 2024 | -69.80M |
| December 31, 2023 | -62.84M |
| Date | Value |
|---|---|
| September 30, 2023 | -122.02M |
| June 30, 2023 | -117.66M |
| March 31, 2023 | -108.87M |
| December 31, 2022 | -105.38M |
| September 30, 2022 | -91.38M |
| June 30, 2022 | -88.92M |
| March 31, 2022 | -82.15M |
| December 31, 2021 | -69.10M |
| September 30, 2021 | -61.62M |
| June 30, 2021 | -49.90M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Nurix Therapeutics, Inc. | -304.53M |
| Gilead Sciences, Inc. | 12.94B |
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Capricor Therapeutics, Inc. | -129.78M |
| Cue Biopharma, Inc. | -50.17M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.11M |
| Cash from Investing (Quarterly) | -28.86M |
| Cash from Financing (Quarterly) | 3.211M |
| Free Cash Flow Per Share (Quarterly) | -0.4813 |
| Free Cash Flow to Equity (Quarterly) | -47.76M |
| Free Cash Flow to Firm (Quarterly) | -48.84M |
| Free Cash Flow Yield | -2.75% |